Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

TDRD3 activates USP9X. 3 / 3

| 3

➶

reach

"Knockdown TDRD3 inhibits the presence of USP9X in the structure of SGs and increases cellular apoptosis (Narayanan et al., 2017)."

34604242

➶

reach

"Furthermore, we found that one of the USP9X de-ubiquitination targets, myeloid cell leukemia protein 1, is regulated by TDRD3, indicating that TDRD3 potentially regulates USP9X de-ubiquitinase activity."

28101374

➶

reach

"This dynamic change was diminished in Tdrd3-null MEFs, suggesting that TDRD3 mediates USP9X SG localization (XREF_FIG)."

28101374

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

TDRD3 activates USP9X. 3 / 3

Our Sources:

Databases

Reading